Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04834817 · ClinicalTrials.gov registry record · NA

Effect of Combined Red and Near Infrared Light-emitting Diode (LED) Therapy on Tissue Regeneration Post Laser Treatment

A NA study of Wound Heal, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT04834817: Completed NA study of Wound Heal, sponsored by University of California, Irvine.

NCT04834817 is a NA study of Wound Heal that has completed, run by University of California, Irvine. The registered enrollment target is 25 participants, below the 119-participant average among 23 other Wound Heal trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04834817, a NA study of Wound Heal, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effect of light therapy on wound healing after laser treatment.

Primary Outcome

The primary endpoint of this study is time and days to complete healing of the treatment sites. Clinical grading shall be by blinded assessment.

Conditions Studied

Interventions

  • DEVICE Celluma POD

Study Locations (1)

California

  • UCI Beckman Laser Institute and Medical Clinic - Irvine

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-04-01
Est. Completion 2024-03-30
Phase NA
University of California, Irvine

368 total trials

What the finished NCT04834817 record still lists

NCT04834817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 119-participant average among 23 other Wound Heal trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Wound Heal appearing as the primary indexed condition, and to 1 intervention - of which Celluma POD is the first listed.

NCT04834817 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04834817 about?

NCT04834817 is a clinical study titled "Effect of Combined Red and Near Infrared Light-emitting Diode (LED) Therapy on Tissue Regeneration Post Laser Treatment". The purpose of this study is to evaluate the effect of light therapy on wound healing after laser treatment.

What is the current status of trial NCT04834817?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2021-04-01. Estimated completion is 2024-03-30.

What conditions does trial NCT04834817 study?

This clinical trial studies the following conditions: Wound Heal.

What interventions are being tested in trial NCT04834817?

The interventions under investigation include: Celluma POD (DEVICE).

Who is sponsoring clinical trial NCT04834817?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04834817 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wound Heal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04834817's enrollment target sits among peer trials

25 20th of 23 higher than 4 of 23 other Wound Heal trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Wound Heal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04834817, the US trial registry maintained by the National Library of Medicine. NCT04834817 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.